Search

everythinglearnresearchcommunity

for

Search:↓

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Overexpressing 14-3-3σ in mice skin reduces cell growth and hair density.

The mineralocorticoid receptor temporarily affects mouse skin development, but the glucocorticoid receptor has a more lasting impact.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Hair transplants are effective for some women and many male-to-female transgender patients if done carefully by an experienced team.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Social rejection can harm long-term mental health in transgender individuals.

Testosterone treatment may affect heart response to stress in transgender men.

New mouse models help study melanocytic cells for melanoma research.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Skin issues from testosterone therapy in transgender men can be managed with combined dermatology and endocrinology care.

Skin issues from testosterone therapy in transgender men can be managed with combined dermatology and endocrinology care.

Laser treatment boosts hair growth by activating a key growth factor.

A gene called Taqpep affects cat coat patterns like stripes and blotches.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Activating the Sonic hedgehog gene in mice can start the hair growth phase.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.

Hair grows faster in the morning and is more vulnerable to damage from radiation due to the internal clock in hair follicle cells.

Overexpressing Dsg3 in mice skin causes excessive cell growth and abnormal skin development.

Too much keratin 16 in mice skin causes abnormal skin thickening and structure.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

The conclusion is that supportive environments are crucial for the mental health and well-being of transgender individuals during gender transition or de-transition.